NCT01637441

Brief Summary

The cystocele is the most frequent clinical shape of the genital prolapse. It is a frequent pathology in woman which can impair quality of life and generates pelvic, urinary or sexual functional disorders. It's considered that 8 % of women will be undergo surgery in this indication before the age of 80 years. Numerous surgical techniques have been described and we distinguish the interventions according to the route (vaginal or abdominal), and according to the use or not of synthetic mesh (non-absorbable) to increase the anatomical results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
262

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2012

Typical duration for not_applicable

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

April 22, 2026

Status Verified

November 1, 2015

Enrollment Period

2.8 years

First QC Date

July 6, 2012

Last Update Submit

April 17, 2026

Conditions

Keywords

bladder prolapse (cystocele)Pelvic organ prolapse repaircoelioscopicprosthetic surgeryvaginal approachRandomized studylaparoscopic sacropexyvaginal mesh surgeryStage IIClavien Dindo

Outcome Measures

Primary Outcomes (1)

  • Morbidity (Dindo Classification)

    Compare the morbidity of the sub-vesical synthetic mesh according to the route between laparoscopic sacropexy or vaginal in the symptomatic superior stage II cystoceles at 1 year follow-up.

    12 months

Secondary Outcomes (3)

  • Specific complications

    12 months

  • Medium-term tolerance

    12 months

  • Clinical Efficiency

    12 months

Study Arms (2)

laparoscopic sacropexy

EXPERIMENTAL

under laparoscopic vision, the vesico-vaginal space is dissected until the level of the bladder neck. a synthetic non absorbable mesh is placed between the bladder and the vagina. the mesh is sutured to the vagina and the apex (vaginal apex or uterus) and anchored to the prevertebral ligament in front of the promontorium.

Procedure: laparoscopic sacropexy

vaginal mesh

EXPERIMENTAL

after anterior sagittal colpotomy, the bladder is dissected under the fascia layer, and the paravesical fossa are entered. a synthetic non absorbable mesh is placed with 4 arms suspension (trans obturator or not). treatment of the apex is mandatory.

Procedure: vaginal mesh

Interventions

under laparoscopic vision, the vesico-vaginal space is dissected until the level of the bladder neck. a synthetic non absorbable mesh is placed between the bladder and the vagina. the mesh is sutured to the vagina and the apex (vaginal apex or uterus) and anchored to the prevertebral ligament in front of the promontorium.

Also known as: laparoscopic surgery
laparoscopic sacropexy
vaginal meshPROCEDURE

after anterior sagittal colpotomy, the bladder is dissected under the fascia layer, and the paravesical fossa are entered. a synthetic non absorbable mesh is placed with 4 arms suspension (trans obturator or not). treatment of the apex is mandatory.

Also known as: medical vaginal device
vaginal mesh

Eligibility Criteria

Age45 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cystocele superior or equal to stage II of the international classification POP-Q, isolated or associated with other elements of prolapse.
  • Patient must have provided written informed consent form prior to enrolment
  • Patient must be insured

You may not qualify if:

  • Previous of surgery for prolapse
  • Unfavourable conditions to one or other of the 2 evaluated procedure
  • Pelvic malignancy in the course of evolution
  • Contraindication to the use of mesh
  • Women not reading French
  • Patients haven't have a social insurance
  • Pregnancy or desire for future pregnancy
  • To be under guardianship or deprived of liberty
  • Simultaneous participation in another biomedical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Sébatien BLANC

Annecy, 74374, France

Location

Hôpital Antoine Béclère

Clamart, 92140, France

Location

CHU Estaing

Clermont-Ferrand, 63003, France

Location

GCS Flandre Maritime

Grande-Synthe, 59760, France

Location

CH La Rochelle Service de Gynécologie Obstétrique

La Rochelle, 17019, France

Location

Hôpital BICETRE / Service de Gynécologie Obstétrique

Le Kremlin-Bicêtre, 94275, France

Location

CHRU de Lille - Service de Gynécologie médico chirurgicale

Lille, 59037, France

Location

CHU de Nîmes

Nîmes, 30029, France

Location

Groupe Hospitalier Diaconesses Croix St-Simon

Paris, 75571, France

Location

CHI Poissy-St-Germain / Service de gynécologie

Poissy, 78303, France

Location

CHU de Poitiers

Poitiers, 86000, France

Location

Hôpital de Hautepierre

Strasbourg, 67000, France

Location

Related Publications (1)

  • Lucot JP, Cosson M, Bader G, Debodinance P, Akladios C, Salet-Lizee D, Delporte P, Savary D, Ferry P, Deffieux X, Campagne-Loiseau S, de Tayrac R, Blanc S, Fournet S, Wattiez A, Villet R, Ravit M, Jacquetin B, Fritel X, Fauconnier A. Safety of Vaginal Mesh Surgery Versus Laparoscopic Mesh Sacropexy for Cystocele Repair: Results of the Prosthetic Pelvic Floor Repair Randomized Controlled Trial. Eur Urol. 2018 Aug;74(2):167-176. doi: 10.1016/j.eururo.2018.01.044. Epub 2018 Feb 19.

MeSH Terms

Conditions

Cystocele

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Jean-Philippe LUCOT, MD

    CHRU de LILLE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2012

First Posted

July 11, 2012

Study Start

September 1, 2012

Primary Completion

July 1, 2015

Study Completion

November 1, 2015

Last Updated

April 22, 2026

Record last verified: 2015-11

Locations